# Magnesium Sulfate

NDC: 0338-1719
Generic name: Magnesium Sulfate Heptahydrate
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200601

FDA application: ANDA211966

## Active ingredients

- MAGNESIUM SULFATE HEPTAHYDRATE: 4 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-1719"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-1719
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea05b8f9-6e11-45c3-824a-4a78818019df